Botulinum Toxin Injections
J15
3 active Medicare policies list K60.4, and 2 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
2 policies from 1 payer
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of K60.4 |
|---|---|---|
| Blood and Adipose Tissue Derived Products for Selected Indications | Oct 26, 2023 | Covered |
| Botulinum Toxin | Jan 1, 2024 | Covered |